FIM
France Intergroupe Syndromes Myéloprolifératifs
FIM
The FIM is a cooperative group of clinicians, biologists and researchers from all over France involved in the diagnosis, management, treatment and research on Ph-negative myeloproliferative disorders.
Prof. Jean-Jacques Kiladjian
Head of Entity
Contact
Email : jean-jacques.kiladjian@aphp.fr
Hôpital Saint Louis AP-HP
1, avenue Claude Vellefaux
75010 Paris - France
Research infrastructures
Preclinical studies | In vivo and in vitro drug testing platform in collaboration with UMR 1131 (Dr Bruno Cassinat) and UMR 944 (Dr Lina Benajiba). |
Clinical investigation center (CIC) | Accredited by INCa as CLIP² Paris Nord since 2010, to facilitate the implementation of early-phase trials in oncology. With continuous improvement at the heart of its activities, the CIC is committed to an Organizational and Participatory Quality approach. |
Biological sample | |
Various sources MPN |
BCB FIMBANK - National multicenter clinical-biological database of myeloproliferative syndromes. |
Various sources Clinical data |
BCB FIMBANK - National multicenter clinical biology database for myeloproliferative disorders. |